Merck (MRK) Net Cash Flow (2009 - 2026)

Merck (MRK) has 18 years of Net Cash Flow data on file, last reported at -$9.3 billion in Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$9.3 billion, down 95.55% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.7 billion (down 221.63% YoY), and the FY2025 annual result was $809.0 million, down 87.93% from the prior year.
• Net Cash Flow eased to -$9.3 billion in Q1 2026 per MRK's latest filing, from -$3.6 billion in the prior quarter.
• Over five years, Net Cash Flow peaked at $10.2 billion in Q3 2025 and troughed at -$9.3 billion in Q1 2026.
• A 5-year average of -$154.9 million and a median of -$1.0 billion in 2024 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2023 and 2024: Net Cash Flow plunged 712.35% in 2023, then soared 245.29% in 2024.
• A 5-year view of Net Cash Flow shows it stood at $1.1 billion in 2022, then slumped by 272.52% to -$1.9 billion in 2023, then soared by 48.46% to -$1.0 billion in 2024, then slumped by 258.23% to -$3.6 billion in 2025, then slumped by 158.09% to -$9.3 billion in 2026.
• Business Quant data shows MRK's Net Cash Flow at -$9.3 billion in Q1 2026, -$3.6 billion in Q4 2025, and $10.2 billion in Q3 2025.